List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Angiotensin II Receptor Blockers Product Introduction
1.2 Global Angiotensin II Receptor Blockers Outlook 2017 VS 2022 VS 2028
1.2.1 Global Angiotensin II Receptor Blockers Sales in US$ Million for the Year 2017-2028
1.2.2 Global Angiotensin II Receptor Blockers Sales in Volume for the Year 2017-2028
1.3 United States Angiotensin II Receptor Blockers Outlook 2017 VS 2022 VS 2028
1.3.1 United States Angiotensin II Receptor Blockers Sales in US$ Million for the Year 2017-2028
1.3.2 United States Angiotensin II Receptor Blockers Sales in Volume for the Year 2017-2028
1.4 Angiotensin II Receptor Blockers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Angiotensin II Receptor Blockers in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Angiotensin II Receptor Blockers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Angiotensin II Receptor Blockers Market Dynamics
1.5.1 Angiotensin II Receptor Blockers Industry Trends
1.5.2 Angiotensin II Receptor Blockers Market Drivers
1.5.3 Angiotensin II Receptor Blockers Market Challenges
1.5.4 Angiotensin II Receptor Blockers Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Angiotensin II Receptor Blockers Market Segment by Type
2.1.1 Azilsartan
2.1.2 Candesartan
2.1.3 Eprosartan
2.1.4 Irbesartan
2.1.5 Losartan
2.1.6 Olmesartan
2.1.7 Telmisartan
2.1.8 Valsartan
2.2 Global Angiotensin II Receptor Blockers Market Size by Type
2.2.1 Global Angiotensin II Receptor Blockers Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Angiotensin II Receptor Blockers Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Angiotensin II Receptor Blockers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Angiotensin II Receptor Blockers Market Size by Type
2.3.1 United States Angiotensin II Receptor Blockers Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Angiotensin II Receptor Blockers Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Angiotensin II Receptor Blockers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Angiotensin II Receptor Blockers Market Segment by Application
3.1.1 Chronic Kidney Diseases
3.1.2 Heart Failure
3.1.3 Kidney Failure in Diabetes
3.2 Global Angiotensin II Receptor Blockers Market Size by Application
3.2.1 Global Angiotensin II Receptor Blockers Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Angiotensin II Receptor Blockers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Angiotensin II Receptor Blockers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Angiotensin II Receptor Blockers Market Size by Application
3.3.1 United States Angiotensin II Receptor Blockers Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Angiotensin II Receptor Blockers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Angiotensin II Receptor Blockers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Angiotensin II Receptor Blockers Competitor Landscape by Company
4.1 Global Angiotensin II Receptor Blockers Market Size by Company
4.1.1 Top Global Angiotensin II Receptor Blockers Manufacturers Ranked by Revenue (2021)
4.1.2 Global Angiotensin II Receptor Blockers Revenue by Manufacturer (2017-2022)
4.1.3 Global Angiotensin II Receptor Blockers Sales by Manufacturer (2017-2022)
4.1.4 Global Angiotensin II Receptor Blockers Price by Manufacturer (2017-2022)
4.2 Global Angiotensin II Receptor Blockers Concentration Ratio (CR)
4.2.1 Angiotensin II Receptor Blockers Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Angiotensin II Receptor Blockers in 2021
4.2.3 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Angiotensin II Receptor Blockers Manufacturing Base Distribution, Product Type
4.3.1 Global Angiotensin II Receptor Blockers Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Angiotensin II Receptor Blockers Product Type
4.3.3 Date of International Manufacturers Enter into Angiotensin II Receptor Blockers Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Angiotensin II Receptor Blockers Market Size by Company
4.5.1 Top Angiotensin II Receptor Blockers Players in United States, Ranked by Revenue (2021)
4.5.2 United States Angiotensin II Receptor Blockers Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Angiotensin II Receptor Blockers Sales by Players (2020, 2021 & 2022)
5 Global Angiotensin II Receptor Blockers Market Size by Region
5.1 Global Angiotensin II Receptor Blockers Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Angiotensin II Receptor Blockers Market Size in Volume by Region (2017-2028)
5.2.1 Global Angiotensin II Receptor Blockers Sales in Volume by Region: 2017-2022
5.2.2 Global Angiotensin II Receptor Blockers Sales in Volume Forecast by Region (2023-2028)
5.3 Global Angiotensin II Receptor Blockers Market Size in Value by Region (2017-2028)
5.3.1 Global Angiotensin II Receptor Blockers Sales in Value by Region: 2017-2022
5.3.2 Global Angiotensin II Receptor Blockers Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Angiotensin II Receptor Blockers Market Size YoY Growth 2017-2028
6.1.2 North America Angiotensin II Receptor Blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Angiotensin II Receptor Blockers Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Angiotensin II Receptor Blockers Market Size YoY Growth 2017-2028
6.3.2 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Angiotensin II Receptor Blockers Market Size YoY Growth 2017-2028
6.4.2 Latin America Angiotensin II Receptor Blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Angiotensin II Receptor Blockers Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Corporation Information
7.1.2 Merck & Co. Description and Business Overview
7.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered
7.1.5 Merck & Co. Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Corporation Information
7.2.2 AstraZeneca Description and Business Overview
7.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.2.4 AstraZeneca Angiotensin II Receptor Blockers Products Offered
7.2.5 AstraZeneca Recent Development
7.3 Novartis
7.3.1 Novartis Corporation Information
7.3.2 Novartis Description and Business Overview
7.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novartis Angiotensin II Receptor Blockers Products Offered
7.3.5 Novartis Recent Development
7.4 Teva
7.4.1 Teva Corporation Information
7.4.2 Teva Description and Business Overview
7.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Teva Angiotensin II Receptor Blockers Products Offered
7.4.5 Teva Recent Development
7.5 Bayer
7.5.1 Bayer Corporation Information
7.5.2 Bayer Description and Business Overview
7.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bayer Angiotensin II Receptor Blockers Products Offered
7.5.5 Bayer Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporation Information
7.6.2 GlaxoSmithKline Description and Business Overview
7.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Products Offered
7.6.5 GlaxoSmithKline Recent Development
7.7 Sun Pharmaceutical
7.7.1 Sun Pharmaceutical Corporation Information
7.7.2 Sun Pharmaceutical Description and Business Overview
7.7.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Products Offered
7.7.5 Sun Pharmaceutical Recent Development
7.8 Mylan
7.8.1 Mylan Corporation Information
7.8.2 Mylan Description and Business Overview
7.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Mylan Angiotensin II Receptor Blockers Products Offered
7.8.5 Mylan Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Angiotensin II Receptor Blockers Industry Chain Analysis
8.2 Angiotensin II Receptor Blockers Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Angiotensin II Receptor Blockers Distributors
8.3 Angiotensin II Receptor Blockers Production Mode & Process
8.4 Angiotensin II Receptor Blockers Sales and Marketing
8.4.1 Angiotensin II Receptor Blockers Sales Channels
8.4.2 Angiotensin II Receptor Blockers Distributors
8.5 Angiotensin II Receptor Blockers Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
